Abstract
During the twentieth century, haemoglobinopathies and Down syndrome were the most frequent hereditary diseases in Greece. Until the 1950s, medical knowledge concerning the mechanism of hereditary transmission was inadequate, thus making the work of physicians very difficult. It was only in the 1960s when the improvement of medical technology and genetics provided physicians with accurate diagnosis of the most widespread anaemia in Greece, Mediterranean Anaemia or beta-Thalassaemia. In Greece, as in the majority of Mediterranean countries, there was a growing concern for this particular disease, because of the high percentage of carriers in the region. As was often expressed at that period of time (1950–1980), Mediterranean anaemia was the prime social and medical problem.
A carrier of Mediterranean anaemia does not have any apparent symptoms, but the defective gene can be easily diagnosed with a simple blood test. Moreover, a defective gene is expressed only when the person inherits it from both parents. Due to the simplicity of the procedure and the safety of the result, many physicians found themselves obliged to recommend preventive measures, such as a simple blood test.
While some considered the counsellor’s involvement in the decision-making of the parents paternalistic, others thought it imperative. Discussion about genetic counselling prevailed during the period under examination and doctors’ opinions varied. Value-neutral information about the risk of the disease and a non-directive approach were most of the time impossible. However, the dominant view among the doctors was that each prospective parent should take their own responsibility towards this problem.
Since the 1960s, there have been numerous epidemiological studies and abundant statistical data dealing with the incidence of the disease. The first Centre for the prevention of Mediterranean Anaemia was established in Athens in 1975. The blood examination which revealed if someone was a carrier was free of charge. The Greek state funded this centre in Athens and smaller units, incorporated in big hospitals, in the rest of the country.
Although some Mediterranean anaemia experts participated in the meetings of the Hellenic Eugenics Society, the prevention of thalassaemia in Greece was not associated with eugenics. Instead, it became part of the preventive policies of the Greek national healthcare system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Kattamis et al. 1970, 502–505.
- 2.
See Weatherall 2010.
- 3.
Cao 2010, 62.
- 4.
See Farmaki and Galanello 2011, 272–280.
- 5.
WHO Working Group 1982, 655.
- 6.
Ibid. and Koutelekos and Haliasos 2013, 101–112.
- 7.
- 8.
- 9.
Malamos 1962, 5–13; Cowan 2008, 192.
- 10.
Caminopetros 1952, 687–693.
- 11.
Loukopoulos 2011, 572.
- 12.
Canali and Corbellini 2006.
- 13.
Dronamraju 2006, 2–4.
- 14.
Canali and Corbellini 2006, 58.
- 15.
Angastiniotis and Eleftheriou 2011, 314.
- 16.
Cooley and Lee 1925, 29.
- 17.
- 18.
- 19.
- 20.
Kattamis 2011a.
- 21.
Thomas et al. 1982.
- 22.
Loukopoulos 2011.
- 23.
- 24.
- 25.
WHO Working Group 1982.
- 26.
- 27.
Malamos et al. 1962.
- 28.
Ibid. 11.
- 29.
Hellenic Eugenics Society 1976, 136.
- 30.
Angastiniotis and Eleftherieu 2011, 313.
- 31.
Modell 1977, 495.
- 32.
Hellenic Eugenics Society 1976.
- 33.
Weindling 1997.
- 34.
Dardavesis 2008.
- 35.
Loukopoulos 2011, 573.
- 36.
Ibid. 575.
- 37.
Ibid.
- 38.
Ibid.
- 39.
- 40.
Ibid.
- 41.
Ibid. 573.
- 42.
- 43.
Cao et al. 1981.
- 44.
Maniatis 2008.
- 45.
- 46.
Service of Crowning or Marriage. The Great Euchologion of the Orthodox Church 2014, 199.
- 47.
Loukopoulos 2011, 575.
- 48.
Angastiniotis et al. 2011, 314.
- 49.
Modell 1980.
- 50.
- 51.
Loukopoulos et al. 1982.
- 52.
Loukopoulos 2011, 575.
- 53.
Loukopoulos 2016: Interview with the author. Athens, Greece.
- 54.
Hellenic Eugenics Society 1978b, 307.
- 55.
Loukopoulos 2011, 574.
- 56.
Hellenic Eugenics Society 1978b, 303.
- 57.
Hellenic Eugenics Society 1978b, 308.
- 58.
Loukopoulos 2011, 574.
- 59.
Hellenic Eugenics Society 1978b, 308.
- 60.
- 61.
Ibid.
- 62.
- 63.
Barmpouti 2015, 40–41.
- 64.
Hellenic Eugenics Society 1978b, 306.
- 65.
- 66.
- 67.
Lane 1955, 198.
- 68.
Bashford 2014.
- 69.
- 70.
Hellenic Eugenics Society 1978a, 7–28.
- 71.
Hellenic Eugenics Society 1976.
- 72.
Hellenic Eugenics Society 1978b.
- 73.
See Bashford and Levine 2010, 3–24.
- 74.
See Turda 2010.
- 75.
Cowan 2009.
- 76.
Canali and Corbellini 2003, 747.
- 77.
Ibid. 3.
- 78.
Greece. Law 300/1968.
- 79.
Hellenic Eugenics Society 1978b, 302.
- 80.
Hellenic Eugenics Society 1976, 124.
- 81.
Loukopoulos 2011, 574.
References
Angastiniotis M, S Kyriakidou, MG Hadjiminas (1986): How Thalassaemia was Controlled in Cyprus. World Health Forum 7: 291-297.
Angastiniotis M, A Eleftheriou (2011): The Prevention of Thalassemia-A Review of the International Scene, Haema 2 (3): 313-318.
Aleporou-Marinou V et al. (1980): Discussion Paper Prenatal Diagnosis of Thalassemia Major in Greece: Evaluation of the First Large Series of Attempts. Annals of the New York Academy of Sciences 344: 181-188.
Ashiotis Th et al. (1973): Thalassaemia in Cyprus. British Medical Journal 2: 38-41.
Barmpouti A (2015): Eugenics and Induced Abortions in post-war Greece. Acta Historiae Medicinae, Stomatologiae, Pharmacie, Veterinae 34 (1): 38-50.
Barnicot NA et al. (1963): Haemoglobin Types in Greek populations. Annals of Human Genetics 26:229-236
Barnicot NA et al. (1965): A Genetical Survey of Sphakia, Crete. Human Biology 37 (3): 274-298.
Bashford A, P Levine (2010): The Oxford Handbook of the History of Eugenics. Oxford: Oxford University Press.
Bashford A (2014): Global Population. History, Geopolitics and Life on Earth. New York: Columbia University Press.
Caminopetros J. (1938a): Recherches sur l’ Anaemia Erythroblastique Infantile, des Peuples de la Mediterranee Orientale. Premier memoire: étude nosologique. Annals of Medicine 43: 27-43.
Caminopetros, J. (1938b), Recherches sur l’ Anaemia Erythroblastique Infantile, des Peoples de la Mediterranee Orientale. Étude anthropologique, étiologique et pathogénique. LaTransmission héréditaire de la maladia. Annals of Medicine 44: 104-125.
Caminopetros J. (1952): The Sickle-Cell Anomaly as a Sign of Mediterranean Anaemia. The Lancet 259 (6710): 687-693.
Canali S, G Corbellini (2003): Lessons from Anti-thalassemia Campaigns in Italy, before Prenatal Diagnosis. Medicina nei Secoli 14 (3): 739-771.
Canali S, G Corbellini (2006) Clinical, Epidemiological, and Genetic Investigations on Thalassemia and Malaria in Italy. In: Dronamraju K, P Arese (2006): Malaria: Genetic and Evolutionary Aspects. New York: Springer. 56-80.
Cao, A et al. (1981): Prevention of Homozygous Beta-Thalassaemia by Carrier Screening and Prenatal Diagnosis in Sardinia. American Journal of Human Genetics 33: 592-605.
Cao, A, R Galanello (2010) Beta-Thalassemia. Genetics in Medicine 12 (2): 61-76.
Centre of Mediterranean Anaemia, Laiko Hospital Athens [http://www.laiko.gr/index.php?option=com_content&view=article&id=81&Itemid=125 accessed 12 January 2016].
Chatzinikolaou, N (2002): Free from genome. Orthodox bioethical approaches. Athens: n.p.
Choremis C et al. (1963): Three Inherited Red Cell Abnormalities in a District of Greece. Thalassemia, Sickle Cell and Glucose 6 Dehydrogenase Deficiency. Lancet 281 (7287): 907-910.
Cooley, TB, P Lee (1925): Series of Cases of Splenomegaly in Children with Anemia and Peculiar Bone Changes. Transactions of the American Pediatric Society 37: 29-30.
Cowan, RS (2008): Heredity and Hope: The Case of Genetic Screening. Cambridge, MA: Harvard Univ. Pr.
Cowan, RS (2009): Moving Up the Slippery Slope: Mandating Genetic Screening on Cyprus. American Journal of Medical Genetics, Part C (Seminars in Medical Genetics) 151C: 95-103.
Dardavesis, Th. (2008) The Historical Course of the Ministry of Health in Greece, 1833-1981. Iatriko Vima 115: 50-61.
David, HP (1992): Abortion in Europe, 1920-91: A public health perspective. Studies in family planning 23 (1): 1-22.
Dronamraju, K (2006) Introduction. In: Dronamraju K, P Arese (2006): Malaria: Genetic and Evolutionary Aspects. New York: Springer. 2-15.
Farmaki, K (2011): Endocrine Complications in Thalassemia. Haema 2 (3): 272-281.
Fessas, P, G Stamatoyannopoulos (1964a): Hereditary Persistence of Fetal Hemoglobin in Greece. A Study and a Comparison. Blood 24: 223-240.
Fessas, P, D Loukopoulos (1964b): Alpha-chain of Human Hemoglobin: Occurrence in vivo. Science 143: 590-591.
Fraser, GR et al. (1964): Thalassemias, Abnormal Hemoglobins and G-6PDd in the Arta area of Greece. Annals of the New York Academy of Sciences 119: 415-435.
Greece Law 1609 (1986): Artificial termination of pregnancy and woman health protection. Official Government Gazette 86: 2303-2305.
Hellenic Eugenics Society (1976): Round Table Discussion: Antenatal Diagnosis. Iatriki 30 (2): 123-187.
Hellenic Eugenics Society (1965): Public Discussions, vol. 1. Athens: Parisianos.
Hellenic Eugenics Society (1977): Public Discussions, vol. 2. Athens: Parisianos.
Hellenic Eugenics Society (1978a): Public Discussions, vol. 3. Athens: Parisianos.
Hellenic Eugenics Society (1978b): Premarital Medical Examination. Materia Medica Greca 6 (4): 299-315.
Kattamis, C et al. (1970): Growth of Children with Thalassaemia: Effect of Different Transfusion Regimens. Archives of Disease in Childhood 45: 502-505.
Kattamis, C et al. (1973): The Clinical and Hematological Findings in Children Inheriting Two Types of Thalassemia: High A2 Type Beta Thalassemia and High F Type of Delta Beta Thalassemia. British Journal of Haematology 25, 3: 375-384.
Kattamis, C et al. (1979): The Heterogeneity of Normal HbA2 β-thalassemia in Greece. British Journal Haematology 42 (1): 109-123.
Kattamis, C et al. (1982): The clinical phenotype of β and δβ Thalassemias in Greece. European Journal of Pediatrics 139, 2: 135-138.
Kattamis, C. (1980): Screening for Hemoglobinopathies. In: Bickel H, R Guthrie, G Hammerseng (eds): Neonatal Screening for Inborn Errors of Metabolism. Berlin, Heidelberg: Springer. 133-147.
Kattamis, C (2011a): Study and Prevention of Mediterranean Anaemia in Greece in Karamperopoulos D. (ed.): History of Greek Paediatrics. Proceedings of the Fourth Meeting in 2009, Hellenic Society of the History of Paediatrics. Athens.
Kattamis, C (2011b): Evolution and Effectiveness of the Greek National Treatment Program for Thalassemia. Haema 2 (3): 330-340.
Koutelekos, J, N Haliasos (2013): Mediterranean Anaemia. Perioperative Nursing 2 (3): 101-112.
Lane, K (1955): Hellenic Eugenics Society. The Eugenics Review 46 (4): 185.
Loukopoulos, D (2011): Haemoglobinopathies in Greece: Prevention Program over the past 35 years. The Indian Journal of Medical Research 134 (4): 572-576.
Loukopoulos, D, P Fessas (1965): The Distribution of Hemoglobin Types in Thalassemic Erythrocytes. Journal of Clinical Investigation 44: 231-240.
Loukopoulos, D et al. (1982): Prenatal Diagnosis of Beta-thalassemia; the Greek Experience. Birth Defects Original Article Series 18 (7): 293-301.
Loukopoulos, D, A Kaltsoya-Tassiopoulou, P Fessas (1983): Prevention of Thalassemia. Schweizerische Medizinische Wochenschrift 113 (40): 1419-1427.
Loukopoulos, D, A Kaltsoya-Tasssiopoulou, P Fessas (1988): Thalassemia Control in Greece. Birth Defects Original Article Series 23 (5B): 405-416.
Loukopoulos, D (2016): Interview with the Author. 13.01.2016. Athens, Greece.
Louros, N (1955): Eugenics. An appeal. Elliniki Iatriki 24 (1): 289-296.
Louros, N (1960): Fertility, Sterility and Overpopulation. International Journal of Fertility 5 (2): 171-173.
Malamos, B, Ph Fessas, G Stamatoyannopoulos (1962): Types of Thalassaemia-Trait Carriers as Revealed by a Study of their Incidence in Greece. British Journal of Haematology 8: 5-13.
Maniatis, G (2008) Opinion of the Hellenic Bioethics Commission on Prenatal and Preimplantation Genetic Diagnosis, paper presented, 27-28 Nov. 2008. In: 12th Forum of National Ethics Councils, Paris.
Mantzarides, G (2009): Christian Ethics. Thessaloniki: Pournaras.
Modell, B (1977): Total Management of Thalassaemia Major. Archives of Disease in Childhood 52: 489-500.
Modell, B, RHT Ward, DIVI Fairweather (1980): Effect of Introducing Antenatal Diagnosis on Reproductive Behaviour of Families at Risk for Thalassaemia Major. British Medical Journal 280: 1347-1350.
Pan-Hellenic Association of Patients with Mediterranean Anaemia [www.paspama.gr accessed 11 July 2016]
Silvestroni, E, I Bianco (1975): Screening of Microcythaemia in Italy; Analysis of Data Collected in the past 30 years. American Journal of Human Genetics 27: 198-212.
Silvestroni, E, I Bianco (1983): A Highly Cost Effective Method of Mass Screening for Thalassaemia, British Medical Journal 286: 1007-1009.
The Great Euchologion of the Orthodox Church (2014). Athens: Papadimitriou Publ.
Thomas ED, JE Buckner, JE Sanders (1982): Marrow Transplantation for Thalassemia. Lancet 2: 227-229.
Turda, M (2010): Modernism and Eugenics. London: Palgrave Macmillan.
United Nations (2002): Abortion policies. A global review.
Vantsos, M (2009): Ethical Consideration of Abortion. Thessaloniki: Sfakianakis Pub.
Weatherall, DJ, JB Clegg (2000): The Thalassemias Syndromes 4th ed. Oxford: Blackwell Scientific Publ.
Weatherall, DJ (2010): Thalassaemia. A biography. Oxford: Oxford University Press.
Weindling, P (1997): Philanthropy and World Health: The Rockefeller Foundation and the League of Nations Health Organization. Minerva 35: 269-281.
WHO Working Group (1982): Hereditary Anaemias: Genetic Basis, Clinical Features, and Treatment. Bulletin of the World Health Organization 60 (5): 643-660.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Barmpouti, A. (2017). Genetic Counselling for Mediterranean Anaemia in Post-war Greece. In: Petermann, H., Harper, P., Doetz, S. (eds) History of Human Genetics. Springer, Cham. https://doi.org/10.1007/978-3-319-51783-4_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-51783-4_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51782-7
Online ISBN: 978-3-319-51783-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)